References
- Hillard T C, Whitcroft S, Ellerington M C, Whitehead M I. The long-term risks, and benefits of hormone replacement therapy. J Clin Pharm Ther 1991; 16: 231–45
- Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart, and Estrogen/Progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280: 605–13
- Lerner D J, Kannel W B. Patterns of coronary heart disease morbidity, and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383–90
- Nieschlag E, Nieschlag S, Behre H M. Lifespan, and testosterone. Nature 1993; 366: 215
- Rockhold R W. Cardiovascular toxicity of anabolic steroids. Annu Rev Phamacol Toxicol 1993; 33: 497–520
- Bagatell C J, Bremner W J. Androgens in men — uses, and abuses. N Engl J Med 1996; 334: 707–14
- McNutt R A, Ferenchick G S, Kirlin P C, Hamlin N J. Acute myocardial infarction in a 22-year-old world-class weight lifter using anabolic steroids. Am J Cardiol 1988; 62: 164
- Adams M R, Williams J K, Kaplan J R. Effects of androgens on coronary artery atherosclerosis, and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol 1995; 15: 562–70
- Obasanjo I O, Clarkson T B, Weaver D S. Effects of the anabolic steroid nandrolone decanoate on plasma lipids, and coronary arteries of female cynomologus macaques. Metabolism 1996; 45: 463–8
- McCrohon J A, Jessup W, Handelsman D J, Celermajer D S. Androgen exposure increases human monocyte adhesion to vascular endothelium, and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999; 99: 2317–22
- Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low-density lipo-protein receptor-deficient mice expressing the scavenger receptor B1 transgene. J Biol Chem 1999; 274: 2366–71
- Feldman H A, Johannes C B, McKinlay J B, Longcope C. Low dehydroepiandrosterone sulfate, and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. Ann Epidemiol 1998; 8: 217–28
- Phillips G B, Pinkernell B H, Jing T Y. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994; 14: 701–6
- Webb C M, Adamson D L, de Zeigler D, Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol 1999; 83: 437–9
- Webb C M, McNeill J G, Hayward C S, et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 1999; 100: 1690–6